<DOC>
	<DOCNO>NCT01496053</DOCNO>
	<brief_summary>Examine whether daily oral ingestion immunomodulatory mushroom extract ( AndoSanTM ) patient ulcerative colitis ( UC ) Crohn ` disease ( CD ) , experience clinical , biochemical genetical improvement disease . A prospective randomise study compare mushroom extract placebo .</brief_summary>
	<brief_title>Anti-inflammatory Effect Agaricus Blazei Murill Inflammatory Bowel Disease ( IBD )</brief_title>
	<detailed_description />
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>moderate disease serious disease , biological treatment , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Cytokine level blood</keyword>
	<keyword>Calprotectin feces</keyword>
	<keyword>Clinical symptom score .</keyword>
</DOC>